 | |
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Protein subunit |
| Clinical data | |
| Trade names | IndoVac |
| Routes of administration | Intramuscular |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
IndoVac is a recombinant protein subunit COVID-19 vaccine,[1][2] developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas.[1][2] It is the world's first officially halal certified COVID-19 vaccine,[3] but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups.[4][5] The vaccine was officially launched by President Joko Widodo on 13 October 2022.[6]
- ^ a b "Indonesian Pharmaceutical Company Bio Farma Ready to Produce 'IndoVac' Covid-19 Vaccines, a New Milestone for Indonesia's Independence in the Pharmaceutical Sector". Bio Farma. 13 September 2022.
- ^ a b "Texas-Developed Patent-Free COVID-19 Vaccine Technology Receives Emergency Use Authorization In Indonesia". Texas Children's Hospital. Archived from the original on 18 October 2022. Retrieved 14 October 2022.
- ^ "Dr. Peter Hotez's halal COVID-19 vaccine approved for use in Indonesia". Houston Chronicle. 3 October 2022.
- ^ "Islamic federation certifies coronavirus vaccines as Halal, but warns misinformation is widespread". SBS Language.
- ^ Waqar A. "Is the COVID-19 vaccine Halal?". SBS Language. Retrieved 16 October 2022.
- ^ "Jokowi launches domestically manufactured IndoVac COVID-19 vaccine". Antara. 13 October 2022.